.png)
CJC-1295
A GHRH analog studied for extended growth hormone pulsatility, commonly referenced alongside Ipamorelin in combined secretagogue research. Supplied lyophilized and matched to a certificate of analysis before it's cataloged.
For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy.
What the research covers.
CJC-1295 is studied for its extended half-life relative to native GHRH, sustaining growth hormone pulsatility in research models. It's most often referenced in combination with a ghrelin-receptor agonist like Ipamorelin.
Every compound we catalog is held to the same 99%+ purity threshold, and we're rolling out independent Vanguard certificates compound by compound. For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy.
Also in the catalog.
